Diseases of the Nervous System | Mental Health & Behavioral Research, Phase II

Intensive 7-day Treatment for PTSD Combining Ketamine With Exposure Therapy (PTSD)

Volunteers
Health Professionals

What is the purpose of this trial?

The purpose of this study is to combine a series of two infusions of Ketamine or midazolam with 7-days of trauma focus psychotherapy to relieve post traumatic stress disorder (PTSD) symptoms more effectively. This treatment has the potential to produce a significant therapeutic effect that otherwise would take months to occur.

Trial with
Yale University School of Medicine and National Center for PTSD (NCPTSD)
Ages
21 years - 70 years
Gender
Both

Find out more about who can participate in this trial

Contact Information

For more information about this study, including how to volunteer, contact PTSD Stress Lab

Help Us Discover!

You can help our team find trials you might be eligible for by creating a volunteer profile in MyChart. To get started, create a volunteer profile, or contact helpusdiscover@yale.edu, or call 877.978.8343 for more information.

Create a volunteer profile

Principal Investigator

Ilan Harpaz-Rotem, PhD, ABPP
Professor of Psychiatry and of Psychology; Director, PTSD Advanced Fellowship in Mental Illness Research and Treatment; Deputy Director, Evaluation Division at the National Center for PTSD, VA Connecticut Healthcare System

Sub-Investigators

Last Updated
10/14/2024
Study HIC
#1509016530